Pharmacokinetics, dosimetry and toxicity of holmium-166-DOTMP for bone marrow ablation in multiple myeloma.
Article 1995 en
Authors
JB
John E. Bayouth
DM
Daniel J. Macey
LK
Leela P. Kasi
Abstract
1 min read
All patients demonstrated severe bone marrow toxicity with a white blood cell (WBC) count < 1,000 cells/microliters, two patients exhibited marrow ablation (WBC count < 100 cells/microliters), and no other toxicity > or = grade 2 was observed in any of the patients.
Michaela R. Reagan, Yuji Mishima, Yong Zhang, Patricia Maiso, Salomon Manier, Yu‐Tzu Tai, Priya Dhir, Zhi Ning Lu, Masoumeh Memarzadeh, Antonio Sacco, Yosra Aljawai, Susanna Santos, John E. Ready, David Kaplan, Aldo M. Roccaro, Irene M. Ghobrial
Christian A. Di Buduo, Pierre Laurent, Carlo Zaninetti, Larissa Lordier, Paolo M. Soprano, Aikaterini Ntai, Serena Barozzi, Alberto Spada, Ida Biunno, Hana Raslová, James B. Bussel, David Kaplan, Carlo L. Balduini, Alessandro Pecci, Alessandra Balduini
Discussion(0)
No comments yet. Be the first to comment.